ANIK logo

Anika Therapeutics (ANIK) Long Term Liabilities

ANIK Annual Total Long Term Liabilities

$27.31 M
-$8.34 M-23.40%

31 December 2023

ANIK Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ANIK Quarterly Long Term Liabilities

$26.05 M
-$148.00 K-0.56%

30 September 2024

ANIK Quarterly Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ANIK Long Term Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-23.4%-12.0%
3 y3 years-51.5%-23.6%
5 y5 years+567.4%-2.5%

ANIK Long Term Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-23.4%at low-32.4%at low
5 y5-year-51.5%+4.8%-79.0%at low
alltimeall time-51.5%>+9999.0%-79.0%>+9999.0%

Anika Therapeutics Long Term Liabilities History

DateAnnualQuarterly
Sept 2024
-
$26.05 M(-0.6%)
June 2024
-
$26.20 M(-2.1%)
Mar 2024
-
$26.75 M(-2.1%)
Dec 2023
$27.31 M(-23.4%)
$27.31 M(-7.8%)
Sept 2023
-
$29.61 M(-5.7%)
June 2023
-
$31.41 M(-4.2%)
Mar 2023
-
$32.79 M(-8.0%)
Dec 2022
$35.65 M(+16.3%)
$35.65 M(-2.2%)
Sept 2022
-
$36.46 M(-5.4%)
June 2022
-
$38.54 M(+30.8%)
Mar 2022
-
$29.46 M(-3.9%)
Dec 2021
$30.66 M(-45.6%)
$30.66 M(-10.1%)
Sept 2021
-
$34.10 M(-2.5%)
June 2021
-
$34.96 M(-9.5%)
Mar 2021
-
$38.62 M(-31.4%)
Dec 2020
$56.34 M(+116.2%)
$56.34 M(-44.1%)
Sept 2020
-
$100.75 M(-18.9%)
June 2020
-
$124.17 M(+57.1%)
Mar 2020
-
$79.03 M(+203.3%)
Dec 2019
$26.05 M(+536.7%)
$26.05 M(-2.4%)
Sept 2019
-
$26.70 M(+2.6%)
June 2019
-
$26.03 M(+0.2%)
Mar 2019
-
$25.99 M(+535.0%)
Dec 2018
$4.09 M(-32.4%)
$4.09 M(-12.8%)
Sept 2018
-
$4.69 M(-25.2%)
June 2018
-
$6.28 M(-2.6%)
Mar 2018
-
$6.45 M(+6.5%)
Dec 2017
$6.05 M(-30.2%)
$6.05 M(-25.6%)
Sept 2017
-
$8.14 M(+9.6%)
June 2017
-
$7.42 M(+4.3%)
Mar 2017
-
$7.12 M(-17.9%)
Dec 2016
$8.67 M(+13.8%)
$8.67 M(-2.9%)
Sept 2016
-
$8.93 M(+14.5%)
June 2016
-
$7.80 M(-5.2%)
Mar 2016
-
$8.22 M(+7.9%)
Dec 2015
$7.62 M(-12.8%)
$7.62 M(-22.6%)
Sept 2015
-
$9.85 M(+3.8%)
June 2015
-
$9.49 M(-2.3%)
Mar 2015
-
$9.71 M(+11.2%)
Dec 2014
$8.74 M(-21.5%)
$8.74 M(-6.6%)
Sept 2014
-
$9.36 M(-0.2%)
June 2014
-
$9.38 M(-4.1%)
Mar 2014
-
$9.78 M(-12.1%)
Dec 2013
$11.13 M(-40.5%)
$11.13 M(-39.3%)
Sept 2013
-
$18.32 M(+6.1%)
June 2013
-
$17.26 M(-3.0%)
Mar 2013
-
$17.79 M(-4.8%)
Dec 2012
$18.69 M(-20.6%)
$18.69 M(-2.9%)
Sept 2012
-
$19.24 M(-5.7%)
June 2012
-
$20.41 M(-7.6%)
Mar 2012
-
$22.09 M(-6.2%)
Dec 2011
$23.54 M(-3.4%)
$23.54 M(+8.1%)
Sept 2011
-
$21.79 M(-4.8%)
June 2011
-
$22.88 M(-1.0%)
Mar 2011
-
$23.11 M(-5.2%)
DateAnnualQuarterly
Dec 2010
$24.38 M(-20.8%)
$24.38 M(-10.2%)
Sept 2010
-
$27.15 M(-2.3%)
June 2010
-
$27.79 M(-7.3%)
Mar 2010
-
$29.98 M(-2.5%)
Dec 2009
$30.77 M(+18.2%)
$30.77 M(+34.3%)
Sept 2009
-
$22.91 M(-4.2%)
June 2009
-
$23.93 M(-4.3%)
Mar 2009
-
$25.02 M(-3.9%)
Dec 2008
$26.03 M(+87.3%)
$26.03 M(+32.8%)
Sept 2008
-
$19.60 M(-4.0%)
June 2008
-
$20.42 M(+18.4%)
Mar 2008
-
$17.25 M(+24.1%)
Dec 2007
$13.90 M(-19.0%)
$13.90 M(-24.6%)
Sept 2007
-
$18.43 M(+3.5%)
June 2007
-
$17.80 M(+7.1%)
Mar 2007
-
$16.62 M(-3.1%)
Dec 2006
$17.16 M(-9.2%)
$17.16 M(-3.6%)
Sept 2006
-
$17.81 M(-3.8%)
June 2006
-
$18.51 M(+1.6%)
Mar 2006
-
$18.23 M(-3.6%)
Dec 2005
$18.90 M(-15.0%)
$18.90 M(-3.4%)
Sept 2005
-
$19.57 M(-3.3%)
June 2005
-
$20.25 M(-5.7%)
Mar 2005
-
$21.47 M(-3.4%)
Dec 2004
$22.23 M(+1134.8%)
$22.23 M(+10.1%)
Sept 2004
-
$20.19 M(+7.9%)
June 2004
-
$18.70 M(-2.9%)
Mar 2004
-
$19.25 M(+969.4%)
Dec 2003
$1.80 M(-36.0%)
$1.80 M(-32.1%)
June 2000
-
$2.65 M(-2.8%)
Mar 2000
-
$2.73 M(-3.1%)
Dec 1999
$2.81 M(+2711.1%)
$2.81 M(+2711.1%)
Dec 1998
$100.00 K(0.0%)
$100.00 K(-50.0%)
Mar 1998
-
$200.00 K(+100.0%)
Dec 1997
$100.00 K(0.0%)
$100.00 K(0.0%)
Sept 1997
-
$100.00 K(-50.0%)
June 1997
-
$200.00 K(+100.0%)
Mar 1997
-
$100.00 K(0.0%)
Dec 1996
$100.00 K(-66.7%)
-
Nov 1996
-
$100.00 K(-66.7%)
Aug 1996
-
$300.00 K(+200.0%)
Aug 1996
$300.00 K(-40.0%)
-
May 1996
-
$100.00 K(-83.3%)
Feb 1996
-
$600.00 K(+20.0%)
Nov 1995
-
$500.00 K(0.0%)
Aug 1995
$500.00 K(-66.7%)
$500.00 K(-16.7%)
May 1995
-
$600.00 K(-60.0%)
Feb 1995
-
$1.50 M(0.0%)
Nov 1994
-
$1.50 M(0.0%)
Aug 1994
$1.50 M(-6.3%)
$1.50 M(-6.3%)
May 1994
-
$1.60 M(0.0%)
Feb 1994
-
$1.60 M(0.0%)
Nov 1993
-
$1.60 M(0.0%)
Aug 1993
$1.60 M
$1.60 M(-11.1%)
May 1993
-
$1.80 M

FAQ

  • What is Anika Therapeutics annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Anika Therapeutics?
  • What is Anika Therapeutics annual total long term liabilities year-on-year change?
  • What is Anika Therapeutics quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Anika Therapeutics?
  • What is Anika Therapeutics quarterly long term liabilities year-on-year change?

What is Anika Therapeutics annual total long term liabilities?

The current annual total long term liabilities of ANIK is $27.31 M

What is the all time high annual total long term liabilities for Anika Therapeutics?

Anika Therapeutics all-time high annual total long term liabilities is $56.34 M

What is Anika Therapeutics annual total long term liabilities year-on-year change?

Over the past year, ANIK annual total long term liabilities has changed by -$8.34 M (-23.40%)

What is Anika Therapeutics quarterly total long term liabilities?

The current quarterly long term liabilities of ANIK is $26.05 M

What is the all time high quarterly long term liabilities for Anika Therapeutics?

Anika Therapeutics all-time high quarterly total long term liabilities is $124.17 M

What is Anika Therapeutics quarterly long term liabilities year-on-year change?

Over the past year, ANIK quarterly total long term liabilities has changed by -$3.56 M (-12.02%)